WuXi PharmaTech

1Q Revenues: $118.0 million (+26%)

1Q Earnings: $21.0 million (+15%)

Comments: Manufacturing services revenue grew 35% to $31.4 million. Laboratory Services revenue grew 23% to $86.6 million, with China-based lab services up 26% to $64.5 million and U.S.-based lab services up 16% to $22.2 million.